Acorda Therapeutics is a biotechnology company based in Ardsley, New York. Acorda Therapeutics develops drugs to improve therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system.[3] Acorda manufactures and markets the drugs Zanaflex and Ampyra in the United States.
History [edit]
 |
This section is empty. You can help by adding to it. (January 2010) |
Corporate governance [edit]
As of December 31, 2008 (2008-12-31)[update] the members of the board of directors of Acorda Therapeutics are:[4] Ron Cohen, Barry Greene, John Kelley, Sandra Panem, Lorin J. Randall, Steven M. Rauscher, Ian F. Smith, and Wise Young.
Products [edit]
Products on the market [edit]
![[icon]](//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/20px-Wiki_letter_w_cropped.svg.png) |
This section requires expansion. (January 2010) |
Products under development [edit]
 |
This section is empty. You can help by adding to it. (January 2010) |
References [edit]
External links [edit]
Hoover's